N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 2 ClinicalTrials.gov

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

Sponsor: KTH Biopharma • ClinicalTrials.gov ID: NCT07698886

Registry updated: 2026-10-20
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Interventions

  • Geniwa gel (Drug)
    Geniwa gel contains alpha lactalbumin-oleic acid 5%
  • Placebo gel (Other)
    Placebo gel contains saline

Eligibility criteria

Inclusion Criteria: 1. 18 years of age or older. 2. Able to read and understand the Patient Information Sheet and the Informed Consent form. 3. Acceptance in the participation of the essay and signature of the Informed Consent form. 4. Diagnosis of genital and anal warts with clear clinical manifestations. 5. Have undergone at least 2 laser or nitrogen treatments and have experienced recurrence in any location. 6. At least four or more lesions, or a lesion area of at least 0.5 cm2. Exclusion Criteria: 1. Concomitant sexually transmitted infections such as gonorrhea, syphilis, genital herpes, etc., that have not been cured. 2. Ulceration or suspected malignant transformation of the lesions. 3. Local infections. 4. Pregnant women. 5. Allergies to any component of alpha-lactalbumin-oleic acid gel.

Conditions

HPV (Human Papillomavirus)-Associated Genital Warts

Locations

  • National Dermatology Hospital, Hanoi, Vietnam. — Hanoi, None (International), Vietnam
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record